5986 related articles for article (PubMed ID: 273993)
21. Unusual variants of melanoma: fact or fiction?
Sagebiel RW
Semin Oncol; 1996 Dec; 23(6):703-8. PubMed ID: 8970590
[TBL] [Abstract][Full Text] [Related]
22. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
[TBL] [Abstract][Full Text] [Related]
23. Ideas in pathology. Malignant melanoma in situ: the evolution of a concept.
Dubow BE; Ackerman AB
Mod Pathol; 1990 Nov; 3(6):734-44. PubMed ID: 2263599
[TBL] [Abstract][Full Text] [Related]
24. Multiple congenital melanocytic naevi presenting with neurofibroma-like lesions complicated by malignant melanoma.
Gach JE; Carr RA; Charles-Holmes R; Harris S
Clin Exp Dermatol; 2004 Sep; 29(5):473-6. PubMed ID: 15347327
[TBL] [Abstract][Full Text] [Related]
25. Oestrogen receptor-beta expression in melanocytic lesions.
Schmidt AN; Nanney LB; Boyd AS; King LE; Ellis DL
Exp Dermatol; 2006 Dec; 15(12):971-80. PubMed ID: 17083364
[TBL] [Abstract][Full Text] [Related]
26. Acral lentiginous melanoma or Hutchinson's melanotic freckle of the extremities. A case report.
Rippey JJ; Lewin JR
S Afr Med J; 1978 Jun; 53(26):1076-7. PubMed ID: 694684
[TBL] [Abstract][Full Text] [Related]
27. Pagetoid melanocytosis: tease or tocsin?
Stern JB; Haupt HM
Semin Diagn Pathol; 1998 Aug; 15(3):225-9. PubMed ID: 9711673
[TBL] [Abstract][Full Text] [Related]
28. Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma.
Sexton M; Sexton CW
Arch Pathol Lab Med; 1991 Feb; 115(2):122-6. PubMed ID: 1992976
[TBL] [Abstract][Full Text] [Related]
29. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
Fröhlich E; Mack AF; Garbe C; Klessen C
Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M
Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136
[TBL] [Abstract][Full Text] [Related]
31. Melanoma in Western Australia in 1980-81: incidence and characteristics of histological types.
English DR; Heenan PJ; Holman CD; Armstrong BK; Blackwell JB; Kelsall GR; Matz LR; Singh A; Ten Seldam RE
Pathology; 1987 Oct; 19(4):383-92. PubMed ID: 3444664
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of a red chromagen in the diagnosis of melanocytic lesions of the conjunctiva.
Jiang K; Brownstein S; Lam K; Burns B; Farmer J
JAMA Ophthalmol; 2014 May; 132(5):622-9. PubMed ID: 24626521
[TBL] [Abstract][Full Text] [Related]
33. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?
Kaleem Z; Lind AC; Humphrey PA; Sueper RH; Swanson PE; Ritter JH; Wick MR
Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331
[TBL] [Abstract][Full Text] [Related]
34. Improvement of malignant/benign ratio in excised melanocytic lesions in the 'dermoscopy era': a retrospective study 1997-2001.
Carli P; De Giorgi V; Crocetti E; Mannone F; Massi D; Chiarugi A; Giannotti B
Br J Dermatol; 2004 Apr; 150(4):687-92. PubMed ID: 15099364
[TBL] [Abstract][Full Text] [Related]
35. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
36. Surface microscopy of naevi and melanomas--clues to melanoma.
Nilles M; Boedeker RH; Schill WB
Br J Dermatol; 1994 Mar; 130(3):349-55. PubMed ID: 8148277
[TBL] [Abstract][Full Text] [Related]
37. Melanomas arising from naevi and de novo melanomas--does origin matter?
Weatherhead SC; Haniffa M; Lawrence CM
Br J Dermatol; 2007 Jan; 156(1):72-6. PubMed ID: 17199569
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours.
Chwirot BW; Kuźbicki Ł
Melanoma Res; 2007 Jun; 17(3):139-45. PubMed ID: 17505259
[TBL] [Abstract][Full Text] [Related]
39. Pigmented penile macules.
Mahto M; Woolley PD; Ashworth J
Int J STD AIDS; 2004 Nov; 15(11):717-9. PubMed ID: 15537454
[TBL] [Abstract][Full Text] [Related]
40. Ocular melanomas.
Rodriguez-Sains RS
Dermatol Clin; 1985 Apr; 3(2):297-307. PubMed ID: 3830492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
